Business profile not generated.
Run python -m application.cli.business_profile run --market US --one VTGN, then regenerate the site.
Issue 000 | U.S. Pilot | US
VTGN
Vistagen Therapeutics, Inc.
Passing
Verified
10-Q | 2026-02-12
Filing currency: USD
Margin of Safety
81.3%
GNNI internal calculation. Market context inputs are retained internally and are not displayed.
- Current Assets
- 63,245,000USD
- Total Liabilities
- 14,136,000USD
- NCAV
- 49,109,000USD
- Cash
- 47,371,000USD
- NCAV per share
- 1.16USD/share
- Evidence
- 10 annual | 20 quarterly
Business Profile
Checklist-driven facts extracted from filing text. Missing fields stay visible.
Known Unknowns
Medium | Share Count
Issue 000 does not yet evaluate share count trend or post-filing dilution beyond Mary's screening flags.
Low | Classification
U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.
Annual Financials
Latest annual periods, newest first. Missing cells render as n/a.
| Metric |
2025-03-31
10-K
USD
|
2024-03-31
10-K
USD
|
2023-03-31
10-K
USD
|
2022-03-31
10-K
USD
|
2021-03-31
10-K
USD
|
2020-03-31
10-K
USD
|
2019-03-31
10-K
USD
|
2018-03-31
10-K
USD
|
2017-03-31
10-K
USD
|
2016-03-31
10-K
USD
|
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 486,000 | 1,064,000 | -227,000 | 1,108,900 | 1,089,500 | 0 | n/a | 0 | 1,250,000 | 0 |
| Operating Income | -55,973,000 | -33,021,000 | -59,268,000 | -47,778,900 | -17,933,800 | -20,801,500 | -24,556,300 | -14,199,600 | -10,248,500 | -17,850,200 |
| Net Income | -51,418,000 | -29,362,000 | -59,247,700 | -47,762,400 | -17,934,200 | -20,774,000 | -24,589,600 | -14,345,900 | -10,255,500 | -47,220,500 |
| Cash From Operations | -42,097,000 | -25,813,000 | -49,715,100 | -45,256,500 | -12,073,500 | -15,757,000 | -14,527,500 | -9,058,300 | -7,262,100 | -4,808,500 |
| Capex | n/a | n/a | n/a | -200,400 | -275,400 | 0 | -174,000 | -1,600 | -239,100 | -26,300 |
| Free Cash Flow | n/a | n/a | n/a | -45,456,900 | -12,348,900 | -15,757,000 | -14,701,500 | -9,059,900 | -7,501,200 | -4,834,800 |
| Cash And Equivalents | 67,131,000 | 119,166,000 | 16,637,600 | 68,135,300 | 103,108,300 | 1,355,100 | 13,100,300 | 10,378,300 | 2,921,300 | 428,500 |
| Accounts Receivable | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0 |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Current Assets | 82,076,000 | 120,672,000 | 17,507,400 | 70,998,000 | 104,117,500 | 1,580,200 | 13,651,200 | 11,023,100 | 3,377,900 | 855,300 |
| Total Assets | 84,341,000 | 123,653,000 | 21,089,200 | 74,643,400 | 108,281,300 | 5,772,300 | 14,011,700 | 11,278,300 | 3,712,200 | 989,800 |
| Total Current Liabilities | 12,612,000 | 5,123,000 | 4,567,400 | 5,765,100 | 4,189,000 | 2,771,300 | 2,800,900 | 1,458,500 | 1,367,500 | 1,794,700 |
| Total Liabilities | 13,951,000 | 9,367,000 | 9,009,200 | 9,928,100 | 16,302,800 | 11,501,700 | 6,936,500 | 4,361,700 | 3,096,400 | 3,967,000 |
| Shareholders Equity | 70,390,000 | 114,286,000 | 12,080,000 | 64,715,300 | 91,978,500 | -5,729,400 | 7,075,200 | 6,916,600 | 615,800 | -2,977,200 |
| Shares Outstanding | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | 30,877,029 | 19,354,500 | 6,958,749 | n/a | n/a | n/a | n/a | n/a | n/a | 1,767,957 |
| Weighted Avg Shares Basic | 30,877,029 | 19,354,500 | 7,163,799 | 206,532,083 | 86,133,644 | n/a | n/a | n/a | n/a | 1,767,957 |
Quarterly Financials
Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.
| Metric |
2025-12-31
10-Q
USD
|
2025-09-30
10-Q
USD
|
2025-06-30
10-Q
USD
|
2025-03-31
10-K
USD
|
2024-12-31
10-Q
USD
|
2024-09-30
10-Q
USD
|
2024-06-30
10-Q
USD
|
2024-03-31
10-K
USD
|
2023-12-31
10-Q
USD
|
2023-09-30
10-Q
USD
|
2023-06-30
10-Q
USD
|
2023-03-31
10-K
USD
|
2022-12-31
10-Q
USD
|
2022-09-30
10-Q
USD
|
2022-06-30
10-Q
USD
|
2022-03-31
10-K
USD
|
2021-12-31
10-Q
USD
|
2021-09-30
10-Q
USD
|
2021-06-30
10-Q
USD
|
2021-03-31
10-K
USD
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 302,000 | 258,000 | 244,000 | -15,000 | 234,000 | 183,000 | 84,000 | 197,300 | 411,400 | 278,300 | 177,000 | 175,900 | 180,000 | -893,000 | 310,100 | 38,900 | 357,900 | 358,000 | 354,100 | 441,900 |
| Operating Income | -19,551,000 | -20,054,000 | -15,804,000 | -14,495,000 | -15,120,000 | -14,227,000 | -12,131,000 | -11,359,000 | -7,884,000 | -6,780,200 | -6,997,800 | -12,239,100 | -9,766,500 | -17,489,300 | -19,773,100 | -16,693,000 | -10,540,200 | -12,799,500 | -7,746,200 | -6,219,000 |
| Net Income | -18,899,000 | -19,417,000 | -15,095,000 | -13,635,000 | -14,089,000 | -12,961,000 | -10,733,000 | -9,521,400 | -6,349,800 | -6,587,700 | -6,903,100 | -12,227,000 | -9,761,200 | -17,483,200 | -19,776,300 | n/a | -23,329,500 | n/a | -7,744,500 | -6,210,900 |
| Cash From Operations | -17,631,000 | -13,759,000 | -18,846,000 | -10,062,000 | -10,280,000 | -10,886,000 | -10,869,000 | -7,197,100 | -4,535,400 | -6,189,600 | -7,890,900 | -7,472,700 | -9,933,300 | -16,340,800 | -15,968,300 | n/a | -23,495,100 | n/a | -6,172,900 | -5,281,900 |
| Capex | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -12,500 | -24,400 | -175,100 | n/a | -50,400 | n/a | -149,900 | n/a |
| Free Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -9,945,800 | -16,365,200 | -16,143,400 | n/a | -23,545,500 | n/a | -6,322,800 | n/a |
| Cash And Equivalents | 47,371,000 | 62,786,000 | 48,985,000 | 67,131,000 | 74,715,000 | 84,246,000 | 102,918,000 | 119,166,000 | 126,559,200 | 37,608,400 | 9,622,300 | 16,637,600 | 25,037,300 | 35,287,200 | 51,986,400 | 68,135,300 | 83,700,200 | 93,627,100 | 97,776,900 | 103,108,300 |
| Total Current Assets | 63,245,000 | 78,934,000 | 66,716,000 | 82,076,000 | 89,941,000 | 99,948,000 | 110,838,000 | 120,672,000 | 128,114,000 | 39,076,200 | 11,578,800 | 17,507,400 | 26,057,500 | 36,913,800 | 54,993,600 | 70,998,000 | 86,770,300 | 96,437,400 | 99,825,800 | 104,117,500 |
| Total Liabilities | 14,136,000 | 14,590,000 | 12,159,000 | 13,951,000 | 11,185,000 | 9,522,000 | 8,745,000 | 9,367,000 | 7,783,200 | 6,550,600 | 8,183,300 | 9,009,200 | 9,034,300 | 11,096,700 | 12,673,600 | 9,928,100 | 10,558,300 | 19,840,000 | 18,290,400 | 16,302,800 |
| Shares Outstanding | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | 42,234,405 | 35,749,160 | 31,930,665 | 30,877,029 | 30,711,872 | 30,632,347 | 30,603,435 | 19,354,500 | 29,388,085 | 10,042,530 | 7,337,005 | 6,958,749 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Basic | 42,234,405 | 35,749,160 | 31,930,665 | 30,877,029 | 30,711,872 | 30,632,347 | 30,603,435 | 19,354,500 | 29,388,085 | 10,042,530 | 7,377,005 | 7,163,799 | 206,838,084 | 206,811,249 | 206,596,724 | 206,532,083 | 202,328,683 | 193,227,841 | 189,924,158 | 86,133,644 |
Audit Trail
NCAV Audit
Official-source inputs remain linked to filing provenance. Derived values are labeled as such.
| Input | Value | Source concept | Filing period | Confidence | Provenance |
|---|---|---|---|---|---|
| Current Assets | 63,245,000USD | us-gaap:AssetsCurrent | 2025-12-31 | 1.00 |
sec/companyfacts/cik=0001411685/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001411685\companyfacts.json |
| Total Liabilities | 14,136,000USD | us-gaap:Liabilities | 2025-12-31 | 1.00 |
sec/companyfacts/cik=0001411685/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001411685\companyfacts.json |
| Cash | 47,371,000USD | us-gaap:CashAndCashEquivalentsAtCarryingValue | 2025-12-31 | 1.00 |
sec/companyfacts/cik=0001411685/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001411685\companyfacts.json |
| Shares Outstanding | 42,234,405 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | 2025-12-31 | 1.00 |
sec/companyfacts/cik=0001411685/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001411685\companyfacts.json |
| NCAV | 49,109,000USD | derived | 2025-12-31 | n/a | company-evidence-v1 | total_current_assets - total_liabilities |
| NCAV per share | 1.16USD | derived | 2025-12-31 | n/a | company-evidence-v1 | NCAV / shares_outstanding |
| Margin of Safety | 81.3% | derived | 2025-12-31 | n/a | gnni_publication_pack | internal_discount |
NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / weighted_avg_shares_diluted
Source Provenance
- Data Source
- Data Vault
- Data Vault Root
- D:\Projects\The Data Vault
- CIK
- 0001411685
- Company ID
- n/a
- Selected Annual Source
- D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001411685\companyfacts.json
- Selected Quarterly Source
- D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001411685\companyfacts.json
- Statement Extractor
- companyfacts-screener-v1
- View Extractor
- companyfacts-screener-v1
- Source Accession Count
- 25
- Imported At
- 2026-07-04T23:04:41+00:00
- Rendered At
- 2026-07-05T09:06:29+00:00
Run Audit
- Mary Run
- 1ec055d81d1a42a39490a83bb9e1f22f
- Mary As Of
- 2026-07-03
- Accession
- 0001628280-26-007718
- CIK
- 0001411685
- Mary Filing Date
- 2026-02-12
- Filing Currency
- USD
- Internal Discount
- 81.3%
- Source State
- Verified
- Market Context
- Not Displayed
- Market Policy
- internal_only_not_redistributed
- Share Trend
- Not Evaluated
- Dilution
- Needs Review
mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2026-02-12; mary_accession=0001628280-26-007718; mary_cik=0001411685; gnni_supporting_filing_date=2026-02-12; internal_discount=0.813399; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.